CSL BEHRING

Live / Applied — Statement of use — registration review complete (as of 29 Sept 2026)

What this means for you

Not registered yet, but its 25 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97236398
Mark type
Word mark
Filed
25 Jan 2022
Published for opposition
13 Jun 2023
Attorney of record
SCOTT D. WOLDOW

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for blood diseases, illnesses and conditions; Pharmaceutical preparations for the treatment or prevention of blood and bleeding disorders; Pharmaceutical preparations for immunology, hematology, respiratory, albumin, transplant, inflammatory, and cardiovascular diseases, illnesses, or conditions; Human blood plasma derived pharmaceutical preparations for the treatment of a wide variety of diseases, illnesses or conditions; pharmaceutical preparations, namely, therapeutic monoclonal and polyclonal antibodies and antibodies for use in the treatment of infectious diseases

Owner

Board proceedings on this mark

The owner also pleads this mark in 4 other Board proceedings.

Prosecution history

  • 29 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 29 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 20 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 31 Jul 2026 — USE AMENDMENT FILED
  • 31 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
  • 03 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 03 Jun 2026 — SOU EXTENSION 5 GRANTED
  • 07 Jan 2026 — SOU EXTENSION 5 FILED
  • 02 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 08 Jan 2026 — SOU TEAS EXTENSION RECEIVED
  • 08 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 08 Jul 2025 — SOU EXTENSION 4 GRANTED
  • 08 Jul 2025 — SOU EXTENSION 4 FILED
  • 08 Jul 2025 — SOU TEAS EXTENSION RECEIVED
  • 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

View this trademark record on Rightsy